|
1
|
Korbet SM: Treatment of primary FSGS in
adults. J Am Soc Nephrol. 23:1769–1776. 2012. View Article : Google Scholar
|
|
2
|
Ponticelli C and Graziani G: Current and
emerging treatments for idiopathic focal and segmental
glomerulosclerosis in adults. Expert Rev Clin Immunol. 9:251–261.
2013. View Article : Google Scholar
|
|
3
|
Chen YM and Liapis H: Focal segmental
glomerulosclerosis: Molecular genetics and targeted therapies. BMC
Nephrol. 16:1012015. View Article : Google Scholar :
|
|
4
|
Taylor J and Flinter F: Familial
haematuria: When to consider genetic testing. Arch Dis Child.
99:857–861. 2014. View Article : Google Scholar
|
|
5
|
Kim YH, Goyal M, Kurnit D, Wharram B,
Wiggins J, Holzman L, Kershaw D and Wiggins R: Podocyte depletion
and glomerulosclerosis have a direct relationship in the
PAN-treated rat. Kidney Int. 60:957–968. 2001. View Article : Google Scholar
|
|
6
|
Wharram BL, Goyal M, Wiggins JE, Sanden
SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman
LB and Wiggins RC: Podocyte depletion causes glomerulosclerosis:
Diphtheria toxin-induced podocyte depletion in rats expressing
human diphtheria toxin receptor transgene. J Am Soc Nephrol.
16:2941–2952. 2005. View Article : Google Scholar
|
|
7
|
Santín S, García-Maset R, Ruíz P, Giménez
I, Zamora I, Peña A, Madrid A, Camacho JA, Fraga G, Sánchez-Moreno
A, et al: Nephrin mutations cause childhood- and adult-onset focal
segmental glomerulosclerosis. Kidney Int. 76:1268–1276. 2009.
View Article : Google Scholar
|
|
8
|
Tonna SJ, Needham A, Polu K, Uscinski A,
Appel GB, Falk RJ, Katz A, Al-Waheeb S, Kaplan BS, Jerums G, et al:
NPHS2 variation in focal and segmental glomerulosclerosis. BMC
Nephrol. 9:132008. View Article : Google Scholar :
|
|
9
|
Gigante M, Pontrelli P, Montemurno E, Roca
L, Aucella F, Penza R, Caridi G, Ranieri E, Ghiggeri GM and
Gesualdo L: CD2AP mutations are associated with sporadic nephritic
syndrome and focal segmental glomerulosclerosis (FSGS). Nephrol
Dial Transplant. 24:1858–1864. 2009. View Article : Google Scholar
|
|
10
|
Hinkes B, Wiggins RC, Gbadegesin R,
Vlangos CN, Seelow D, Nürnberg G, Garg P, Verma R, Chaib H, Hoskins
BE, et al: Positional cloning uncovers mutations in PLCE1
responsible for a nephrotic syndrome variant that may be
reversible. Nat Genet. 38:1397–1405. 2006. View Article : Google Scholar
|
|
11
|
Santín S, Ars E, Rossetti S, Salido E,
Silva I, García-Maset R, Giménez I, Ruíz P, Mendizábal S, Nieto
Luciano J, et al: TRPC6 mutational analysis in a large cohort of
patients with focal segmental glomerulosclerosis. Nephrol Dial
Transplant. 24:3089–3096. 2009. View Article : Google Scholar
|
|
12
|
Hall G, Gbadegesin RA, Lavin P, Wu G, Liu
Y, Oh EC, Wang L, Spurney RF, Eckel J, Lindsey T, et al: A novel
missense mutation of Wilms'tumor1 causes autosomal dominant FSGS. J
Am Soc Nephrol. 26:831–843. 2015. View Article : Google Scholar
|
|
13
|
Boyer O, Woerner S, Yang F, Oakeley EJ,
Linghu B, Gribouval O, Tête MJ, Duca JS, Klickstein L, Damask AJ,
et al: LMX1B mutations cause hereditary FSGS without extrarenal
involvement. J Am Soc Nephrol. 24:1216–1222. 2013. View Article : Google Scholar :
|
|
14
|
Boerkoel CF, Takashima H, John J, Yan J,
Stankiewicz P, Rosenbarker L, André JL, Bogdanovic R, Burguet A,
Cockfield S, et al: Mutant chromatin remodeling protein SMARCAL1
causes Schimke immuno-osseous dysplasia. Nat Genet. 30:215–220.
2002. View Article : Google Scholar
|
|
15
|
Choi HJ, Lee BH, Cho HY, Moon KC, Ha IS,
Nagata M, Choi Y and Cheong HI: Familial focal segmental
glomerulosclerosis associated with an ACTN4 mutation and paternal
germline mosaicism. Am J Kidney Dis. 51:834–838. 2008. View Article : Google Scholar
|
|
16
|
Gbadegesin RA, Lavin PJ, Hall G,
Bartkowiak B, Homstad A, Jiang R, Wu G, Byrd A, Lynn K, Wolfish N,
et al: Inverted formin 2 mutations with variable expression in
patients with sporadic and hereditary focal and segmental
glomerulosclerosis. Kidney Int. 81:94–99. 2012. View Article : Google Scholar
|
|
17
|
Lowik MM, Hol FA, Steenbergen EJ, Wetzels
JF and van den Heuvel LP: Mitochondrial tRNALeu (UUR) mutation in a
patient with steroid-resistant nephrotic syndrome and focal
segmental glomerulosclerosis. Nephrol Dial Transplant. 20:336–341.
2005. View Article : Google Scholar
|
|
18
|
Diomedi-Camassei F, Di Giandomenico S,
Santorelli FM, Caridi G, Piemonte F, Montini G, Ghiggeri GM, Murer
L, Barisoni L, Pastore A, et al: COQ2 nephropathy: A newly
described inherited mitochondriopathy with primary renal
involvement. J Am Soc Nephrol. 18:2773–2780. 2007. View Article : Google Scholar
|
|
19
|
López LC, Schuelke M, Quinzii CM, Kanki T,
Rodenburg RJ, Naini A, Dimauro S and Hirano M: Leigh syndromewith
nephropathy and CoQ10 deficiency due to decaprenyl diphosphate
synthase subunit 2 (PDSS2) mutations. Am J Hum Genet. 79:1125–1129.
2006. View
Article : Google Scholar :
|
|
20
|
Matejas V, Hinkes B, Alkandari F,
Al-Gazali L, Annexstad E, Aytac MB, Barrow M, Bláhová K,
Bockenhauer D, Cheong HI, et al: Mutations in the human laminin
beta2 (LAMB2) gene and the associated phenotypic spectrum. Hum
Mutat. 31:992–1002. 2010. View Article : Google Scholar :
|
|
21
|
Hata D, Miyazaki M, Seto S, Kadota E, Muso
E, Takasu K, Nakano A, Tamai K, Uitto J, Nagata M, et al: Nephrotic
syndrome and aberrant expression of laminin isoforms in glomerular
basement membranes for an infant with Herlitz junctional
epidermolysis bullosa. Pediatrics. 116:e601–e607. 2005. View Article : Google Scholar
|
|
22
|
Kambham N, Tanji N, Seigle RL, Markowitz
GS, Pulkkinen L, Uitto J and D'Agati VD: Congenital focal segmental
glomerulosclerosis associated with beta4 integrin mutation and
epidermolysis bullosa. Am J Kidney Dis. 36:190–196. 2000.
View Article : Google Scholar
|
|
23
|
Berkovic SF, Dibbens LM, Oshlack A, Silver
JD, Katerelos M, Vears DF, Lüllmann-Rauch R, Blanz J, Zhang KW,
Stankovich J, et al: Array-based gene discovery with three
unrelated subjects shows SCARB2/LIMP-2 deficiency causes myoclonus
epilepsy and glomerulosclerosis. Am J Hum Genet. 82:673–684. 2008.
View Article : Google Scholar :
|
|
24
|
Serebrinsky G, Calvo M, Fernandez S, Saito
S, Ohno K, Wallace E, Warnock D, Sakuraba H and Politei J: Late
onset variants in Fabry disease: Results in high risk population
screenings in Argentina. Mol Genet Metab Rep. 4:19–24. 2015.
View Article : Google Scholar :
|
|
25
|
Rood IM, Deegens JK and Wetzels JF:
Genetic causes of focal segmental glomerulosclerosis: Implications
for clinical practice. Nephrol Dial Transplant. 27:882–890. 2012.
View Article : Google Scholar
|
|
26
|
Bierzynska A, Soderquest K and Koziell A:
Genes and podocytes-new insights into mechanisms of podocytopathy.
Front Endocrinol (Lausanne). 5:2262015.
|
|
27
|
Kashtan CE: Familial haematuria. Pediatr
Nephrol. 24:1951–1958. 2009. View Article : Google Scholar
|
|
28
|
Piqueras AI, White RH, Raafat F, Moghal N
and Milford DV: Renal biopsy diagnosis in children presenting with
haematuria. Pediatr Nephrol. 12:386–391. 1998. View Article : Google Scholar
|
|
29
|
Vivante A, Afek A, Frenkel-Nir Y, Tzur D,
Farfel A, Golan E, Chaiter Y, Shohat T, Skorecki K and
Calderon-Margalit R: Persistent asymptomatic isolated microscopic
hematuria in Israeli adolescents and young adults and risk for
end-stage renal disease. JAMA. 306:729–736. 2011. View Article : Google Scholar
|
|
30
|
Collar JE, Ladva S, Cairns TD and Cattell
V: Red cell traverse through thin glomerular basement membranes.
Kidney Int. 59:2069–2072. 2001. View Article : Google Scholar
|
|
31
|
Chow KM, Kwan BC, Li PK and Szeto CC:
Asymptomatic isolated microscopic haematuria: Long-term follow-up.
QJM. 97:739–745. 2004. View Article : Google Scholar
|
|
32
|
Moreno JA, Martín-Cleary C, Gutiérrez E,
Rubio-Navarro A, Ortiz A, Praga M and Egido J: Haematuria: The
forgotten CKD factor? Nephrol Dial Transplant. 27:28–34. 2012.
View Article : Google Scholar
|
|
33
|
Gale DP: How benign is hematuria? Using
genetics to predict prognosis. Pediatr Nephrol. 28:1183–1193. 2013.
View Article : Google Scholar
|
|
34
|
Deltas C, Pierides A and Voskarides K:
Molecular genetics of familial hematuric diseases. Nephrol Dial
Transplant. 28:2946–2960. 2013. View Article : Google Scholar
|
|
35
|
Pei Y and Watnick T: Diagnosis and
screening of autosomal dominant polycystic kidney disease. Adv
Chronic Kidney Dis. 17:140–152. 2010. View Article : Google Scholar :
|
|
36
|
Renkema KY, Stokman MF, Giles RH and
Knoers NV: Next-generation sequencing for research and diagnostics
in kidney disease. Nat Rev Nephrol. 10:433–444. 2014. View Article : Google Scholar
|
|
37
|
Buetow KH, Edmonson M, MacDonald R,
Clifford R, Yip P, Kelley J, Little DP, Strausberg R, Koester H,
Cantor CR and Braun A: High-throughput development and
characterization of a genomewide collection of gene-based single
nucleotide polymorphism markers by chip-based matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry. Proc Natl
Acad Sci USA. 98:581–584. 2001. View Article : Google Scholar :
|
|
38
|
Opdal SH, Rognum TO, Torgersen H and Vege
A: Mitochondrial DNA point mutations detected in four cases of
sudden infant death syndrome. Acta Paediat. 88:957–960. 1999.
View Article : Google Scholar
|
|
39
|
Xie J, Wu X, Ren H, Wang W, Wang Z, Pan X,
Hao X, Tong J, Ma J, Ye Z, et al: COL4A3 mutations cause focal
segmental glomerulosclerosis. J Mol Cell Biol. 7:1842015.
View Article : Google Scholar
|
|
40
|
Opdal SH, Vege A, Egeland T, Musse MA and
Rognum TO: Possible role of mtDNA mutations in sudden infant death.
Pediatr Neurol. 27:23–29. 2002. View Article : Google Scholar
|
|
41
|
Moares CT, Ciacci F, Bonilla E, Jansen C,
Hirano M, Rao N, Lovelace RE, Rowland LP, Schon EA and DiMauro S:
Two novel pathogenic mitochondrial DNA mutations affecting
organelle number and protein synthesis. Is the tRNA(Leu(UUR)) gene
an etiologic hot spot? J Clin Invest. 92:2906–2915. 1993.
View Article : Google Scholar :
|
|
42
|
Mochizuki H, Joh K, Kawame H, Imadachi A,
Nozaki H, Ohashi T, Usui N, Eto Y, Kanetsuna Y and Aizawa S:
Mitochondrial encephalomyopathies preceded by de-Toni-Debré-Fanconi
syndrome or focal segmental glomerulosclerosis. Clin Nephrol.
46:347–352. 1996.
|
|
43
|
Kurogouchi F, Oguchi T, Mawatari E,
Yamaura S, Hora K, Takei M, Sekijima Y, Ikeda SI and Kiyosawa K: A
case of mitochondrial cytopathy with a typical point mutation for
MELAS, presenting with severe focal-segmental glomerulosclerosis as
main clinical manifestation. Am J Nephrol. 18:551–556. 1998.
View Article : Google Scholar
|
|
44
|
Hotta O, Inoue CN, Miyabayashi S, Furuta
T, Takeuchi A and Taguma Y: Clinical and pathologic features of
focal segmental glomerulosclerosis with mitochondrial tRNALeu(UUR)
gene mutation. Kidney Int. 59:1236–1243. 2001. View Article : Google Scholar
|
|
45
|
Yamagata K, Muro K, Usui J, Hagiwara M,
Kai H, Arakawa Y, Shimizu Y, Tomida C, Hirayama K, Kobayashi M and
Koyama A: Mitochondrial DNA mutations in focal segmental
glomerulosclerosis lesions. J Am Soc Nephrol. 13:1816–1823. 2002.
View Article : Google Scholar
|
|
46
|
Guéry B, Choukroun G, Noël LH, Clavel P,
Rötig A, Lebon S, Rustin P, Bellané-Chantelot C, Mougenot B,
Grünfeld JP and Chauveau D: The spectrum of systemic involvement in
adults presenting with renal lesion and mitochondrial tRNA(Leu)
gene mutation. J Am Soc Nephrol. 14:2099–2108. 2003. View Article : Google Scholar
|
|
47
|
Hao H and Moares CT: Functional and
molecular mitochondrial abnormalities associated with a C->T
transition at position 3256 of the human mitochondrial genome. The
effects of a pathogenic mitochondrial tRNA point mutation in
organelle translation and RNA processing. J Biol Chem.
271:2347–2352. 1996. View Article : Google Scholar
|
|
48
|
Sadowski CE, Lovric S, Ashraf S, Pabst WL,
Gee HY, Kohl S, Engelmann S, Vega-Warner V, Fang H, Halbritter J,
et al: A single-gene cause in 29.5% of cases of steroid-resistant
nephrotic syndrome. J Am Soc Nephrol. 26:1279–1289. 2015.
View Article : Google Scholar
|
|
49
|
Halbritter J, Baum M, Hynes AM, Rice SJ,
Thwaites DT, Gucev ZS, Fisher B, Spaneas L, Porath JD, Braun DA, et
al: Fourteen monogenic genes account for 15% of
nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol. 26:543–551.
2015. View Article : Google Scholar
|
|
50
|
Deltas C, Pierides A and Voskarides K: The
role of molecular genetics in diagnosing familial hematuria(s).
Pediatr Nephrol. 27:1221–1231. 2012. View Article : Google Scholar
|
|
51
|
Malone AF, Phelan PJ, Hall G, Cetincelik
U, Homstad A, Alonso AS, Jiang R, Lindsey TB, Wu G, Sparks MA, et
al: Rare hereditary COL4A3/COL4A4 variants maybe mistaken for
familial focal segmental glomerulosclerosis. Kidney Int.
86:1253–1259. 2014. View Article : Google Scholar :
|
|
52
|
Liapis H and Jain S: The interface of
genetics with pathology in alport nephritis. J Am Soc Nephrol.
24:1925–1927. 2013. View Article : Google Scholar :
|
|
53
|
Abrahamson DR, Hudson BG, Stroganova L,
Borza DB and St John PL: Cellular origins of type IV collagen
networks in developing glomeruli. J Am Soc Nephrol. 20:1471–1479.
2009. View Article : Google Scholar :
|
|
54
|
Kruegel J, Rubel D and Gross O: Alport
syndrome-insights from basic and clinical research. Nat Rev
Nephrol. 9:170–178. 2013. View Article : Google Scholar
|
|
55
|
Pierides A, Voskarides K, Athanasiou Y,
Ioannou K, Damianou L, Arsali M, Zavros M, Pierides M, Vargemezis
V, Patsias C, et al: Clinico-pathological correlations in 127
patients in 11 large pedigrees, segregating one of three
heterozygous mutations in the COL4A3/COL4A4 genes associated with
familial haematuria and significant late progression to proteinuria
and chronic kidney disease from focal segmental glomerulosclerosis.
Nephrol Dial Transplant. 24:2721–2729. 2009. View Article : Google Scholar
|
|
56
|
Ramzan K, Imtiaz F, Taibah K, Alnufiee S,
Akhtar M, Al-Hazzaa SA and Al-Owain M: COL4A4-related nephropathy
caused by a novel mutation in a large consanguineous Saudi family.
Int J Pediatr Otorhinolaryngol. 78:427–432. 2014. View Article : Google Scholar
|
|
57
|
Bullich G, Trujillano D, Santín S,
Ossowski S, Mendizábal S, Fraga G, Madrid Á, Ariceta G, Ballarín J,
Torra R, et al: Targeted next-generation sequencing in
steroid-resistant nephrotic syndrome: Mutations in multiple
glomerular genes may influence disease severity. Eur J Hum Genet.
23:1192–1199. 2015. View Article : Google Scholar
|
|
58
|
Artuso R, Fallerini C, Dosa L, Scionti F,
Clementi M, Garosi G, Massella L, Epistolato MC, Mancini R, Mari F,
et al: Advances in Alport syndrome diagnosis using next-generation
sequencing. Eur J Hum Genet. 20:50–57. 2012. View Article : Google Scholar
|
|
59
|
Savige J, Gregory M, Gross O, Kashtan C,
Ding J and Flinter F: Expert guidelines for the management of
Alport syndrome and thin basement membrane nephropathy. J Am Soc
Nephrol. 24:364–375. 2013. View Article : Google Scholar
|
|
60
|
Chapter 6: Idiopathic focal segmental
glomerulosclerosis in adults. Kidney Int Suppl (2011). 2:181–185.
2012. View Article : Google Scholar :
|
